BraskemMEX:BAKN 48 EBITDA Margin % is 22.35% as of Mar. 2026, which is 143% above its 10-year median of 9.21. GuruFocus rates MEX:BAKN with a GF Score™ of 48/100 and a GF Value™ of MXN134.71 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,584 Chemicals companies, Braskem ranks better than 59.09% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Braskem's EBITDA for the
three
months ended in Mar. 2026 was MXN11,934 Mil. Braskem's Revenue for the
three
months ended in Mar. 2026 was MXN53,406 Mil. Therefore, Braskem's EBITDA margin for the quarter that ended in Mar. 2026 was 22.35%.
Braskem (MEX:BAKN) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Braskem EBITDA Margin % Related Terms
Braskem EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Braskem's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Braskem's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Braskem EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Braskem's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Braskem's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braskem (MEX:BAKN) has a EBITDA Margin % of 22.35% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Braskem and its competitors. This is 143% above median its historical median of 9.21. According to the industry distribution chart, Braskem ranks #648 out of 1584 companies in the Chemicals industry, placing it in the top 40.9%.
Is Braskem's EBITDA Margin % too high?
Braskem's current EBITDA Margin % of 22.35% is 143% above median its 10-year median of 9.21. The Chemicals industry median EBITDA Margin % is 9.64. Braskem's value of 22.35% is 132% above this industry median. Based on the distribution chart, Braskem ranks #648 out of 1584 companies in the Chemicals industry, which is above the industry midpoint. Overall, Braskem has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Braskem's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Braskem ranks #648 out of 1584 companies for EBITDA Margin %. This puts Braskem in the upper half of its industry. The industry median EBITDA Margin % is 9.64. Braskem's value of 22.35% is 132% above this benchmark. While the company's 10-year median is 9.21 vs. the industry median of 9.64, Braskem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Braskem's current EBITDA Margin % of 22.35% is 132% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Braskem and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Braskem's current EBITDA Margin % is 22.35%, which is 143% above median its own 10-year median of 9.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braskem stock overvalued right now?
Based on GuruFocus' analysis, Braskem (MEX:BAKN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN134.71, compared to a current price of MXN57.50 — trading 57.3% below its estimated fair value. The current EBITDA Margin % is 22.35%, which is 143% above median its 10-year median of 9.21 and 132% above the Chemicals industry median of 9.64. Braskem's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Braskem (MEX:BAKN), the current EBITDA Margin % is 22.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Braskem (MEX:BAKN) Overvalued in 2026?
Based on GuruFocus' analysis, Braskem stock appears to be undervalued.
The current stock price of MXN57.50 is trading 57.3% below its estimated GF Value™ of MXN134.71.
GuruFocus considers Braskem to be Possible Value Trap.
Key valuation signals for MEX:BAKN:
EBITDA Margin %: 22.35% (143% above median its 10-year median of 9.21)
GF Value™: MXN134.71 vs. price of MXN57.50 (57.3% below fair value)
Industry Position: 132% above the Chemicals median (#648 of 1584)
No single metric tells the full story. See the MEX:BAKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.
48GF Score
Get the complete analysis for MEX:BAKN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BAKN has been successfully added to your 
